New evidence demonstrates link between smoking, prostate cancer prognosis
the ONA take:
The association between smoking and the development of various forms of cancer are well established; however, evidence of such a link with prostate cancer is contradictory.
Now, an international study led by MedUni Vienna and Basle University Hospital has found evidence of a clear link.
The study combined data on 7,191 patients with prostate cancer who underwent radical prostatectomy, with no preoperative treatments.
The results showed that risk of biochemical recurrence of prostate for smokers and ex-smokers was twice that of nonsmokers. However, this negative effect can be offset within 10 years of quitting.
Although this research still does not clarify, in scientific terms, whether smoking is associated with the development of prostate cancer, it does demonstrate that smoking increases the risk of dying from the disease.
The researchers acknowledge that further research is needed, but stress the significance of quitting smoking even for those who are already suffering from prostate cancer.
Association between smoking and development of various forms of cancer well established; however, evidence of prostate cancer link contradictory.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|